S. Saydah, J. Fradkin, and C. Cowie, Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed Diabetes, JAMA, vol.291, issue.3, pp.335-342, 2004.
DOI : 10.1001/jama.291.3.335

S. Inzucchi, R. Bergenstal, J. Buse, M. Diamant, E. Ferrannini et al., Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American diabetes association (ADA) and the European association for the study of diabetes (EASD), Diabetologia, vol.55, pp.577-596, 2012.

R. Holman, S. Paul, M. Bethel, D. Matthews, and H. Neil, 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes, New England Journal of Medicine, vol.359, issue.15, pp.1577-1589, 2008.
DOI : 10.1056/NEJMoa0806470

A. Pfalzgraf and D. Nau, DG1: THE RELATIONSHIP OF DIABETES SYMPTOMS AND HEALTH-RELATED QUALITY OF LIFE, Value in Health, vol.4, issue.2, p.58, 2001.
DOI : 10.1046/j.1524-4733.2001.40201-29.x

J. Hill, M. Nielsen, and M. Fox, Understanding the Social Factors That Contribute to Diabetes: A Means to Informing Health Care and Social Policies for the Chronically Ill, The Permanente Journal, vol.17, issue.2, pp.67-72, 2013.
DOI : 10.7812/TPP/12-099

I. Raz, M. Riddle, J. Rosenstock, J. Buse, S. Inzucchi et al., Personalized management of hyperglycemia in type 2 diabetes. Diabetes Care, pp.1779-1788, 2013.

R. Rubin and M. Peyrot, Quality of life and diabetes, Diabetes/Metabolism Research and Reviews, vol.47, issue.3, pp.205-218, 1999.
DOI : 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O

M. Gulliford and D. Mahabir, Relationship of Health-Related Quality of Life to Symptom Severity in Diabetes Mellitus, Journal of Clinical Epidemiology, vol.52, issue.8, pp.773-780, 1999.
DOI : 10.1016/S0895-4356(99)00053-0

S. Maddigan, S. Majumdar, E. Toth, D. Feeny, and J. Johnson, Health-related quality of life deficits associated with varying degrees of disease severity in type 2 diabetes, Health and Quality of Life Outcomes, vol.1, issue.1, p.78, 2003.
DOI : 10.1186/1477-7525-1-78

M. Davies and J. Speight, Patient-reported outcomes in trials of incretin-based therapies in patients with type 2 diabetes mellitus, Diabetes, Obesity and Metabolism, vol.41, issue.Suppl. 1, pp.882-892, 2012.
DOI : 10.1111/j.1463-1326.2012.01595.x

K. Aloumanis, M. Benroubi, S. Sourmeli, and V. Drossinos, Clinical outcomes and costs for patients with type 2 diabetes mellitus initiating insulin therapy in Greece: two-year experience from the INSTIGATE study. Prim Care Diabetes 2013

M. Ali, P. Feeney, D. Hire, D. Simmons, O. Connor et al., Glycaemia and correlates of patient-reported outcomes in ACCORD trial participants, Diabetic Medicine, vol.17, issue.7, pp.67-74, 2012.
DOI : 10.1111/j.1464-5491.2011.03532.x

S. Gönen, K. Güngör, A. Çilli, Ü. Kam??, Z. Akp?nar et al., Comprehensive analysis of health related quality of life in patients with diabetes: a study from Konya Turkey, pp.81-88, 2007.

J. Best, K. Boye, R. Rubin, D. Cao, T. Kim et al., Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily, Diabetic Medicine, vol.118, issue.7, pp.722-728, 2009.
DOI : 10.1111/j.1464-5491.2009.02752.x

J. Best, R. Rubin, M. Peyrot, Y. Li, P. Yan et al., Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment. Diabetes Care, pp.314-319, 2011.

K. Boye, L. Matza, A. Oglesby, K. Malley, S. Kim et al., Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes, Health and Quality of Life Outcomes, vol.4, issue.1, p.80, 2006.
DOI : 10.1186/1477-7525-4-80

J. Ware and M. Hamel, Pragmatic Trials ??? Guides to Better Patient Care?, New England Journal of Medicine, vol.364, issue.18, pp.1865-1867, 2011.
DOI : 10.1056/NEJMp1103502

R. Ligthelm, V. Borzì, J. Gumprecht, R. Kawamori, Y. Wenying et al., Importance of Observational Studies in Clinical Practice, Clinical Therapeutics, vol.29, issue.6, pp.1284-1292, 2007.
DOI : 10.1016/j.clinthera.2007.07.004

C. Mann, Observational research methods. Research design II: cohort, cross sectional, and case-control studies, Emergency Medicine Journal, vol.20, issue.1, pp.54-60, 2003.
DOI : 10.1136/emj.20.1.54

S. Matthaei, M. Reaney, C. Mathieu, C. Östenson, T. Krarup et al., Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study, Diabetes Therapy, vol.28, issue.1, p.6, 2012.
DOI : 10.1007/s13300-012-0006-7

C. Mathieu, C. Ostenson, S. Matthaei, M. Reaney, T. Krarup et al., Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE, Diabetes Therapy, vol.344, issue.2
DOI : 10.1007/s13300-013-0037-8

C. Östenson, S. Matthaei, M. Reaney, T. Krarup, B. Guerci et al., Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries. Diabetes Metab Syn Obesity: Targets and Therapy

U. Kiiskinen, S. Matthaei, M. Reaney, C. Mathieu, C. Ostenson et al., Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study, ClinicoEconomics and Outcomes Research
DOI : 10.2147/CEOR.S44060

R. Kolotkin, R. Crosby, K. Kosloski, and G. Williams, Development of a Brief Measure to Assess Quality of Life in Obesity, Obesity Research, vol.97, issue.Suppl 21, pp.102-111, 2001.
DOI : 10.1038/oby.2001.13

R. Kolotkin, J. Norquist, R. Crosby, S. Suryawanshi, P. Teixeira et al., One-year health-related quality of life outcomes in weight loss trial participants: comparison of three measures, Health and Quality of Life Outcomes, vol.7, issue.1, p.53, 2009.
DOI : 10.1186/1477-7525-7-53

E. Group, EuroQol-a new facility for the measurement of healthrelated quality of life. Health Policy, pp.199-208, 1990.

P. Krabbe, T. Weijnen, R. Rabin, F. De-charro, and . Dordrecht, Guidelines for analysing and reporting EQ-5D outcomes. In The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective, 2003.
DOI : 10.1007/978-94-017-0233-1_2

K. Meadows, C. Abrams, and A. Sandbaek, Adaptation of the Diabetes Health Profile (DHP-1) for use with patients with Type 2 diabetes mellitus: psychometric evaluation and cross-cultural comparison, Diabetic Medicine, vol.20, issue.8, pp.572-580, 2000.
DOI : 10.1023/A:1008878031176

A. Zigmond and R. Snaith, The Hospital Anxiety and Depression Scale, Acta Psychiatrica Scandinavica, vol.141, issue.6, pp.361-370, 1983.
DOI : 10.1111/j.1600-0447.1983.tb09716.x

S. Jones, M. Benroubi, C. Castell, A. Goday, A. Liebl et al., Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study*, Current Medical Research and Opinion, vol.25, issue.3, pp.691-700, 2009.
DOI : 10.1185/03007990902739669

B. Zinman, W. Schmidt, A. Moses, N. Lund, and S. Gough, Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme, Diabetes, Obesity and Metabolism, vol.11, issue.S1, pp.77-82, 2012.
DOI : 10.1111/j.1463-1326.2011.01493.x

R. Jaeschke, J. Singer, and G. Guyatt, Measurement of health status, Controlled Clinical Trials, vol.10, issue.4, pp.407-415, 1989.
DOI : 10.1016/0197-2456(89)90005-6

G. Guyatt, D. Osoba, A. Wu, K. Wyrwich, and G. Norman, Methods to Explain the Clinical Significance of Health Status Measures, Mayo Clinic Proceedings, vol.77, issue.4, pp.371-383, 2002.
DOI : 10.4065/77.4.371

G. Barton, T. Sach, M. Doherty, A. Avery, C. Jenkinson et al., An assessment of the discriminative ability of the EQ-5D index, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditions

B. Mulhern and K. Meadows, Estimating the minimally important difference (MID) of the diabetes health profile-18 (DHP-18) for type 1 and type 2 diabetes mellitus. Discussion paper, 2011.

M. Puhan, M. Frey, S. Büchi, and H. Schünemann, The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease, Health and Quality of Life Outcomes, vol.6, issue.1, p.46, 2008.
DOI : 10.1186/1477-7525-6-46

R. Crosby, R. Kolotkin, and G. Williams, An integrated method to determine meaningful changes in health-related quality of life, Journal of Clinical Epidemiology, vol.57, issue.11, pp.1153-1160, 2004.
DOI : 10.1016/j.jclinepi.2004.04.004

K. Wyrwich, J. Norquist, W. Lenderking, and S. Acaster, Industry Advisory Committee of International Society for Quality of Life Research (ISOQOL): Methods for interpreting change over time in patientreported outcome measures, Qual Life Res, 2012.

L. Matza, K. Boye, N. Yurgin, J. Brewster-jordan, S. Mannix et al., Utilities and disutilities for type 2 diabetes treatment-related attributes, Quality of Life Research, vol.3, issue.Suppl, pp.1251-1265, 2007.
DOI : 10.1007/s11136-007-9226-0

K. Boye, L. Matza, K. Walter, K. Van-brunt, A. Palsgrove et al., Utilities and disutilities for attributes of injectable treatments for type 2 diabetes, The European Journal of Health Economics, vol.4, issue.Suppl 2, pp.219-230, 2011.
DOI : 10.1007/s10198-010-0224-8

R. Bergenstal, L. Garrison, . Jr, L. Miller, L. Hou et al., Exenatide BID Observational Study (ExOS): results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes in a real-world setting, Current Medical Research and Opinion, vol.27, issue.12, pp.2335-2342, 2011.
DOI : 10.1185/03007995.2011.628305

S. Grandy, K. Fox, and . Group, Change in health status (EQ-5D) over 5 years among individuals with and without type 2 diabetes mellitus in the SHIELD longitudinal study, Health and Quality of Life Outcomes, vol.10, issue.1, p.99, 2012.
DOI : 10.1186/1477-7525-5-70

V. Bouwman, M. Adriaanse, E. Van-'t-riet, F. Snoek, and J. Dekker, Depression, Anxiety and Glucose Metabolism in the General Dutch Population: The New Hoorn Study, PLoS ONE, vol.26, issue.4, p.9971, 2010.
DOI : 10.1371/journal.pone.0009971.t005

J. Speight, M. Reaney, and K. Barnard, Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes, Diabetic Medicine, vol.4, issue.4, pp.315-327, 2009.
DOI : 10.1111/j.1464-5491.2009.02682.x

C. Bradley, C. Todd, T. Gorton, E. Symonds, A. Martin et al., The development of an individualized questionnaire measure of perceived